A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo

Anthony Antonellis, Megan Y. Dennis, Grzegorz Burzynski, Jimmy Huynh, Valerie Maduro, Chani J. Hodonsky, Mehrdad Khajavi, Kinga Szigeti, Sandeep Mukkamala, Seneca L. Bessling, William J. Pavan, Andrew S McCallion, James R. Lupski, Eric D. Green

Research output: Contribution to journalArticle

Abstract

Background: Myelin protein zero (MPZ) is a critical structural component of myelin in the peripheral nervous system. The MPZ gene is regulated, in part, by the transcription factors SOX10 and EGR2. Mutations in MPZ, SOX10, and EGR2 have been implicated in demyelinating peripheral neuropathies, suggesting that components of this transcriptional network are candidates for harboring disease-causing mutations (or otherwise functional variants) that affect MPZ expression. Methodology: We utilized a combination of multi-species sequence comparisons, transcription factor-binding site predictions, targeted human DNA re-sequencing, and in vitro and in vivo enhancer assays to study human non-coding MPZ variants. Principal Findings: Our efforts revealed a variant within the first intron of MPZ that resides within a previously described SOX10 binding site is associated with decreased enhancer activity, and alters binding of nuclear proteins. Additionally, the genomic segment harboring this variant directs tissue-relevant reporter gene expression in zebrafish. Conclusions: This is the first reported MPZ variant within a cis-acting transcriptional regulatory element. While we were unable to implicate this variant in disease onset, our data suggests that similar non-coding sequences should be screened for mutations in patients with neurological disease. Furthermore, our multi-faceted approach for examining the functional significance of non-coding variants can be readily generalized to study other loci important for myelin structure and function.

Original languageEnglish (US)
Article numbere14346
JournalPLoS One
Volume5
Issue number12
DOIs
StatePublished - 2010

Fingerprint

myelin proteins
Myelin P0 Protein
myelin sheath
Myelin Sheath
mutation
SOXE Transcription Factors
Early Growth Response Protein 2
Mutation
binding sites
transcription factors
Transcriptional Regulatory Elements
Binding Sites
peripheral nervous system
peripheral nervous system diseases
Gene Regulatory Networks
nuclear proteins
Peripheral Nervous System
Neurology
Peripheral Nervous System Diseases
Zebrafish

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Antonellis, A., Dennis, M. Y., Burzynski, G., Huynh, J., Maduro, V., Hodonsky, C. J., ... Green, E. D. (2010). A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo. PLoS One, 5(12), [e14346]. https://doi.org/10.1371/journal.pone.0014346

A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo. / Antonellis, Anthony; Dennis, Megan Y.; Burzynski, Grzegorz; Huynh, Jimmy; Maduro, Valerie; Hodonsky, Chani J.; Khajavi, Mehrdad; Szigeti, Kinga; Mukkamala, Sandeep; Bessling, Seneca L.; Pavan, William J.; McCallion, Andrew S; Lupski, James R.; Green, Eric D.

In: PLoS One, Vol. 5, No. 12, e14346, 2010.

Research output: Contribution to journalArticle

Antonellis, A, Dennis, MY, Burzynski, G, Huynh, J, Maduro, V, Hodonsky, CJ, Khajavi, M, Szigeti, K, Mukkamala, S, Bessling, SL, Pavan, WJ, McCallion, AS, Lupski, JR & Green, ED 2010, 'A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo', PLoS One, vol. 5, no. 12, e14346. https://doi.org/10.1371/journal.pone.0014346
Antonellis A, Dennis MY, Burzynski G, Huynh J, Maduro V, Hodonsky CJ et al. A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo. PLoS One. 2010;5(12). e14346. https://doi.org/10.1371/journal.pone.0014346
Antonellis, Anthony ; Dennis, Megan Y. ; Burzynski, Grzegorz ; Huynh, Jimmy ; Maduro, Valerie ; Hodonsky, Chani J. ; Khajavi, Mehrdad ; Szigeti, Kinga ; Mukkamala, Sandeep ; Bessling, Seneca L. ; Pavan, William J. ; McCallion, Andrew S ; Lupski, James R. ; Green, Eric D. / A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo. In: PLoS One. 2010 ; Vol. 5, No. 12.
@article{3d866ca1f3f14be2926f79aa20992e56,
title = "A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo",
abstract = "Background: Myelin protein zero (MPZ) is a critical structural component of myelin in the peripheral nervous system. The MPZ gene is regulated, in part, by the transcription factors SOX10 and EGR2. Mutations in MPZ, SOX10, and EGR2 have been implicated in demyelinating peripheral neuropathies, suggesting that components of this transcriptional network are candidates for harboring disease-causing mutations (or otherwise functional variants) that affect MPZ expression. Methodology: We utilized a combination of multi-species sequence comparisons, transcription factor-binding site predictions, targeted human DNA re-sequencing, and in vitro and in vivo enhancer assays to study human non-coding MPZ variants. Principal Findings: Our efforts revealed a variant within the first intron of MPZ that resides within a previously described SOX10 binding site is associated with decreased enhancer activity, and alters binding of nuclear proteins. Additionally, the genomic segment harboring this variant directs tissue-relevant reporter gene expression in zebrafish. Conclusions: This is the first reported MPZ variant within a cis-acting transcriptional regulatory element. While we were unable to implicate this variant in disease onset, our data suggests that similar non-coding sequences should be screened for mutations in patients with neurological disease. Furthermore, our multi-faceted approach for examining the functional significance of non-coding variants can be readily generalized to study other loci important for myelin structure and function.",
author = "Anthony Antonellis and Dennis, {Megan Y.} and Grzegorz Burzynski and Jimmy Huynh and Valerie Maduro and Hodonsky, {Chani J.} and Mehrdad Khajavi and Kinga Szigeti and Sandeep Mukkamala and Bessling, {Seneca L.} and Pavan, {William J.} and McCallion, {Andrew S} and Lupski, {James R.} and Green, {Eric D.}",
year = "2010",
doi = "10.1371/journal.pone.0014346",
language = "English (US)",
volume = "5",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - A rare myelin protein zero (MPZ) variant alters enhancer activity in Vitro and in Vivo

AU - Antonellis, Anthony

AU - Dennis, Megan Y.

AU - Burzynski, Grzegorz

AU - Huynh, Jimmy

AU - Maduro, Valerie

AU - Hodonsky, Chani J.

AU - Khajavi, Mehrdad

AU - Szigeti, Kinga

AU - Mukkamala, Sandeep

AU - Bessling, Seneca L.

AU - Pavan, William J.

AU - McCallion, Andrew S

AU - Lupski, James R.

AU - Green, Eric D.

PY - 2010

Y1 - 2010

N2 - Background: Myelin protein zero (MPZ) is a critical structural component of myelin in the peripheral nervous system. The MPZ gene is regulated, in part, by the transcription factors SOX10 and EGR2. Mutations in MPZ, SOX10, and EGR2 have been implicated in demyelinating peripheral neuropathies, suggesting that components of this transcriptional network are candidates for harboring disease-causing mutations (or otherwise functional variants) that affect MPZ expression. Methodology: We utilized a combination of multi-species sequence comparisons, transcription factor-binding site predictions, targeted human DNA re-sequencing, and in vitro and in vivo enhancer assays to study human non-coding MPZ variants. Principal Findings: Our efforts revealed a variant within the first intron of MPZ that resides within a previously described SOX10 binding site is associated with decreased enhancer activity, and alters binding of nuclear proteins. Additionally, the genomic segment harboring this variant directs tissue-relevant reporter gene expression in zebrafish. Conclusions: This is the first reported MPZ variant within a cis-acting transcriptional regulatory element. While we were unable to implicate this variant in disease onset, our data suggests that similar non-coding sequences should be screened for mutations in patients with neurological disease. Furthermore, our multi-faceted approach for examining the functional significance of non-coding variants can be readily generalized to study other loci important for myelin structure and function.

AB - Background: Myelin protein zero (MPZ) is a critical structural component of myelin in the peripheral nervous system. The MPZ gene is regulated, in part, by the transcription factors SOX10 and EGR2. Mutations in MPZ, SOX10, and EGR2 have been implicated in demyelinating peripheral neuropathies, suggesting that components of this transcriptional network are candidates for harboring disease-causing mutations (or otherwise functional variants) that affect MPZ expression. Methodology: We utilized a combination of multi-species sequence comparisons, transcription factor-binding site predictions, targeted human DNA re-sequencing, and in vitro and in vivo enhancer assays to study human non-coding MPZ variants. Principal Findings: Our efforts revealed a variant within the first intron of MPZ that resides within a previously described SOX10 binding site is associated with decreased enhancer activity, and alters binding of nuclear proteins. Additionally, the genomic segment harboring this variant directs tissue-relevant reporter gene expression in zebrafish. Conclusions: This is the first reported MPZ variant within a cis-acting transcriptional regulatory element. While we were unable to implicate this variant in disease onset, our data suggests that similar non-coding sequences should be screened for mutations in patients with neurological disease. Furthermore, our multi-faceted approach for examining the functional significance of non-coding variants can be readily generalized to study other loci important for myelin structure and function.

UR - http://www.scopus.com/inward/record.url?scp=78650735250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650735250&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0014346

DO - 10.1371/journal.pone.0014346

M3 - Article

VL - 5

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e14346

ER -